Concepedia

Author

Robert W. Holloway

Florida Hospital Cancer InstituteORCID

Also Known As

R Holloway, R W Holloway, R. Holloway, R. W. Holloway, R.W. Holloway, Robert Holloway, Robert W Holloway, Robert W. Holloway

243

Publications

8.6K

Citations

38

H-Index

70

Concepts

All Affiliations

Florida Hospital Cancer InstituteThe Ohio State UniversityMemorial Sloan Kettering Cancer CenterThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteEuropean Institute of Oncology
RW

About

Robert W. Holloway is an author at Florida Hospital Cancer Institute specializing in medicine, obstetrics, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

38

5.7K

2

Health Sciences

5

5

271

3

Public Health

3

3

63

4

Engineering

1

1

155

5

Anesthesia

1

1

14

Robert W. Holloway

×

59

Publications

5.5K

Citations

33

H-Index

YearCitations

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso,

The Lancet

2017

1.7K

Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma

Panagiotis A. Konstantinopoulos, Steven Waggoner, Gregory A. Vidal,

JAMA Oncology

2019

533

Robotically assisted laparoscopic hysterectomy versus total abdominal hysterectomy and lymphadenectomy for endometrial cancer

Sara A. DeNardis, Robert W. Holloway, Glenn E. Bigsby,

Gynecologic Oncology

2008

183

Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study

Shitanshu Uppal, Paola A. Gehrig, Katherine Peng,

Journal of Clinical Oncology

2020

163

Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: A comparison of colorimetric and fluorescence imaging

Robert W. Holloway, Ricardo A. Molero Bravo, J.A. Rakowski,

Gynecologic Oncology

2012

155

Robot-assisted versus open radical hysterectomy: A multi-institutional experience for early-stage cervical cancer

B.M. Sert, John F. Boggess, Sarfraz Ahmad,

European Journal of Surgical Oncology

2016

151

Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study

Paul Sabbatini, Philipp Harter, Giovanni Scambia,

Journal of Clinical Oncology

2013

143

TOPACIO/Keynote-162 (NCT02657889): A phase 1/2 study of niraparib + pembrolizumab in patients (pts) with advanced triple-negative breast cancer or recurrent ovarian cancer (ROC)—Results from ROC cohort.

Panagiotis A. Konstantinopoulos, Steven Waggoner, Gregory A. Vidal,

Journal of Clinical Oncology

2018

138

Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells

P Yue, Xiaolei Zhang, David Paladino,

Oncogene

2011

135

Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis

Robert W. Holloway, Sarika Gupta, Nicole M. Stavitzski,

Gynecologic Oncology

2016

127

Page 1